Related Experiment Video
Updated: May 12, 2026

Retroviral Transduction of T-cell Receptors in Mouse T-cells
Published on: October 22, 2010
Mature T-cell lymphomagenesis induced by retroviral insertional activation of Janus kinase 1
Tim Heinrich1, Benjamin Rengstl, Alexander Muik
1Senckenberg Institute of Pathology, Goethe-University Hospital, Frankfurt am Main, Germany.
Abstract:
Retroviral vectors (RVs) are powerful tools in clinical gene therapy. However, stable genomic integration of RVs can be oncogenic, as reported in several animal models and in clinical trials. Previously, we observed that T-cell receptor (TCR) polyclonal mature T cells are resistant to transformation after gammaretroviral transfer of (proto-)oncogenes, whereas TCR-oligoclonal T cells were transformable in the same setting. Here, we describe the induction of a mature T-cell lymphoma (MTCL) in TCR-oligoclonal OT-I transgenic T cells, transduced with an enhanced green fluorescent protein (EGFP)-encoding gammaretroviral vector. The tumor cells were of a mature T-cell phenotype and serially transplantable. Integration site analysis revealed a proviral hit in Janus kinase 1 (Jak1), which resulted in Jak1 overexpression and Jak/STAT-pathway activation, particularly via signal transducer and activator of transcription 3 (STAT3). Specific inhibition of Jak1 markedly delayed tumor growth. A systematic meta-analysis of available gene expression data on human mature T-cell lymphomas/leukemias confirmed the relevance of Jak/STAT overexpression in sporadic human T-cell tumorigenesis. To our knowledge, this is the first study to describe RV-associated insertional mutagenesis in mature T cells.
Insights
Retroviral vectors can cause cancer by integrating into T cells. This study shows oncogenic integration in mature T cells, activating the Janus kinase 1 (Jak1)/STAT3 pathway and leading to lymphoma.
Area of Science:
- Oncology
- Molecular Biology
- Gene Therapy
Background:
- Retroviral vectors (RVs) are utilized in gene therapy but can cause oncogenesis via genomic integration.
- Previous studies indicated mature T cells are resistant to transformation, unlike oligoclonal T cells.
Purpose of the Study:
- To investigate retroviral vector-associated insertional mutagenesis in mature T cells.
- To characterize the mechanism of mature T-cell lymphoma (MTCL) induction by RVs.
Main Methods:
- Induction of MTCL in TCR-oligoclonal OT-I transgenic T cells using an EGFP-encoding gammaretroviral vector.
- Integration site analysis to identify proviral insertions.
- Assessment of Janus kinase 1 (Jak1) and STAT3 pathway activation.
- Meta-analysis of human T-cell lymphoma/leukemia gene expression data.
Main Results:
- Successfully induced serially transplantable MTCL in T cells transduced with RVs.
- Identified a proviral insertion in the Jak1 gene, leading to its overexpression and activation of the Jak/STAT pathway (specifically STAT3).
- Inhibition of Jak1 significantly impeded tumor growth.
- Human T-cell lymphomas/leukemias show relevance of Jak/STAT pathway activation.
Conclusions:
- This study is the first to demonstrate RV-associated insertional mutagenesis in mature T cells.
- Jak1/STAT3 pathway activation is a key mechanism in RV-induced mature T-cell tumorigenesis.
- Findings highlight potential risks of RVs in gene therapy and relevance to human T-cell malignancies.
More Related Videos
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Mechanisms of Retrovirus-induced Cancers
The JAK-STAT Signaling Pathway
T Cell Activation and Clonal Selection
Naive T cells that have not yet encountered an antigen express two primary CD...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

